SE513436C2 - Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus - Google Patents

Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus

Info

Publication number
SE513436C2
SE513436C2 SE9900177A SE9900177A SE513436C2 SE 513436 C2 SE513436 C2 SE 513436C2 SE 9900177 A SE9900177 A SE 9900177A SE 9900177 A SE9900177 A SE 9900177A SE 513436 C2 SE513436 C2 SE 513436C2
Authority
SE
Sweden
Prior art keywords
formic acid
warts
treatment
wart
medicament
Prior art date
Application number
SE9900177A
Other languages
English (en)
Swedish (sv)
Other versions
SE9900177D0 (sv
SE9900177L (sv
Inventor
Astrid Agholme
Original Assignee
Astrid Agholme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20414173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE513436(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrid Agholme filed Critical Astrid Agholme
Priority to SE9900177A priority Critical patent/SE513436C2/sv
Publication of SE9900177D0 publication Critical patent/SE9900177D0/xx
Priority to AT00902251T priority patent/ATE249820T1/de
Priority to PCT/SE2000/000088 priority patent/WO2000045808A1/en
Priority to ES00902251T priority patent/ES2207486T3/es
Priority to AU23379/00A priority patent/AU2337900A/en
Priority to DE60005299T priority patent/DE60005299T2/de
Priority to EP00902251A priority patent/EP1143966B1/en
Priority to US09/889,740 priority patent/US6503946B1/en
Publication of SE9900177L publication Critical patent/SE9900177L/xx
Publication of SE513436C2 publication Critical patent/SE513436C2/sv
Priority to NO20013605A priority patent/NO329470B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9900177A 1999-01-21 1999-01-21 Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus SE513436C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9900177A SE513436C2 (sv) 1999-01-21 1999-01-21 Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
US09/889,740 US6503946B1 (en) 1999-01-21 2000-01-18 Preparation for warts
EP00902251A EP1143966B1 (en) 1999-01-21 2000-01-18 Preparation for warts
ES00902251T ES2207486T3 (es) 1999-01-21 2000-01-18 Preparacion para verrugas.
PCT/SE2000/000088 WO2000045808A1 (en) 1999-01-21 2000-01-18 Preparation for warts
AT00902251T ATE249820T1 (de) 1999-01-21 2000-01-18 Zubereitung für warzen
AU23379/00A AU2337900A (en) 1999-01-21 2000-01-18 Preparation for warts
DE60005299T DE60005299T2 (de) 1999-01-21 2000-01-18 Zubereitung für warzen
NO20013605A NO329470B1 (no) 1999-01-21 2001-07-20 Anvendelse av et preparat omfattende maursyre for fremstilling av et medikament til behandling av hudvorter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9900177A SE513436C2 (sv) 1999-01-21 1999-01-21 Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus

Publications (3)

Publication Number Publication Date
SE9900177D0 SE9900177D0 (sv) 1999-01-21
SE9900177L SE9900177L (sv) 2000-07-22
SE513436C2 true SE513436C2 (sv) 2000-09-11

Family

ID=20414173

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900177A SE513436C2 (sv) 1999-01-21 1999-01-21 Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus

Country Status (9)

Country Link
US (1) US6503946B1 (es)
EP (1) EP1143966B1 (es)
AT (1) ATE249820T1 (es)
AU (1) AU2337900A (es)
DE (1) DE60005299T2 (es)
ES (1) ES2207486T3 (es)
NO (1) NO329470B1 (es)
SE (1) SE513436C2 (es)
WO (1) WO2000045808A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7128903B2 (en) 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
BG106215A (bg) * 2001-12-12 2003-06-30 ПАНЧЕВ Владимир Средство за радикално лечение на туморите, възпалителни процеси, гъбични образувания и други изменения на тъканите, диагностика и профилактика и методи за прилагането му
EP2431030B1 (en) * 2010-09-17 2015-11-11 Abbell AB Treatment of fungal infections
PT2460509T (pt) 2010-12-06 2018-02-13 Abbex Ab Composição para tratamento de verrugas
CN104363885A (zh) * 2012-05-28 2015-02-18 阿贝克斯公司 用于疣的治疗的组合物
EP2692332B1 (en) * 2012-05-29 2019-08-21 Unigroup ApS Composition for the treatment of callus, corns and psoriasis
FR3018687B1 (fr) * 2014-03-19 2017-04-14 Patrick Lepeytre " composition a base d'acides carboxyliques et son application pour le traitement des hyperkeratoses " -
EP3205340A1 (en) * 2016-02-10 2017-08-16 Winko Beheer B.V. Composition for treating skin disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86573A1 (de) * 1986-09-08 1988-04-05 Chimicasa Gmbh Verfahren und praeparat zum inaktivieren von viren innerhalb lebender menschlicher oder tierischer organismen
EP0527241B1 (de) 1991-07-15 1994-03-16 Artesan Pharma Gesellschaft mit beschränkter Haftung Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
GB9621990D0 (en) * 1996-10-22 1996-12-18 Scotia Pharma Ltd Use
DE19736265C2 (de) 1997-08-15 2002-10-31 Phytexpert Pharm Tox Consultin Arzneimittel zur Behandlung von Hauterkrankungen

Also Published As

Publication number Publication date
NO20013605L (no) 2001-09-20
EP1143966A1 (en) 2001-10-17
ATE249820T1 (de) 2003-10-15
AU2337900A (en) 2000-08-25
DE60005299D1 (de) 2003-10-23
DE60005299T2 (de) 2004-07-01
NO329470B1 (no) 2010-10-25
NO20013605D0 (no) 2001-07-20
US6503946B1 (en) 2003-01-07
EP1143966B1 (en) 2003-09-17
ES2207486T3 (es) 2004-06-01
SE9900177D0 (sv) 1999-01-21
WO2000045808A1 (en) 2000-08-10
SE9900177L (sv) 2000-07-22

Similar Documents

Publication Publication Date Title
JP5396125B2 (ja) 被膜形成型製剤
Edy et al. Formulation and evaluation of hydrogel containing Tagetes erecta L. Leaves etanolic extract
KR20010041527A (ko) 국소적 항바이러스성 조성물로서 무기 아질산염 및유기산의 조성
SE513436C2 (sv) Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
US9370533B2 (en) Wound healing compositions comprising microspheres
WO2017080048A1 (zh) 一种用于浅度烧伤的喷膜剂及其制备方法
CN110974861A (zh) 一种艾纳香油脂质体
CN110269839A (zh) 一种大麻二酚cbd及其纳米乳在荨麻疹或/和鼻炎制剂中的应用
BR112020014955A2 (pt) Regime de dosagem de canabinoides para acne
RU2633060C2 (ru) Композиции для пилинга, содержащие трихлоруксусную кислоту (тху) и фенол для снижения жжения, вызванного пилингом с применением тху
US8173183B2 (en) Mucosal membrane healant and moisturizer
CN107753933B (zh) 一种用于鼻腔给药的fgf1脂质体及其制备方法和应用
ES2561814T3 (es) Tratamiento de infecciones micóticas
BERCSTRESSER et al. Treatment of hyperhidrosis with topical methenamine
RU2812221C1 (ru) Средство для лечения ран кожи и мягких тканей
Kovács et al. Lack of the effect of topical vitamin K on bruising after mechanical injury
CN109498598B (zh) 一种温度敏感型中药液体创可贴及其制备方法
RU2790837C2 (ru) Спрей для лечения инфицированных и неинфицированных ран при сахарном диабете i типа
US20160015630A1 (en) Sprayable oxygenated saline composition and method for treating nasal congestion, allergy, dryness, eye irritation, throat irritation, wounds, and skin as applied to human tissues
Yuryeva et al. Prospects for the creation of extemporaneous ointment with urea
Schmidt Warts: their diagnosis and treatment
Curtis Initial management of the burn wound patient
WO2024049361A1 (en) Mixtures of cannabinoid-based compositions and active substances from other genera for medical applications and associates
Camarasa Contact dermatitis due to Bronopol.
JPS6257566A (ja) 水虫治療用塗布剤

Legal Events

Date Code Title Description
NUG Patent has lapsed